Alzheimer's Disease and the Disablement Process: Directions for Future Research

REFERENCES

• Borkowska A., Ziolkowska-Kochan M., Rybakowski J. K. One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: Improvement on ADAS-cog and TMT A, no change or worsening on other tests. Human Psychopharmacology 2005; 20(6)409–414
   Google Scholar
• Bottiggi K. A., Salazar J. C., Lu L., Caban-Holt A. M., Ryan M., Schmitt F. A. Concommitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: Impact on cognitive and physical functioning in Alzhiemer's disease. American Journal of Geriatric Psychiatry 2007; 15: 357–359
   PubMedGoogle Scholar
• Brandt E. N., Pope A. M. Models of Disability and Rehabilitation. Enabling America: Assessing the Role of Rehabilitation Science and Engineering. National Academy Press, Washington, DC 1997
   Google Scholar
• CBO. Projections for long-term care services for the elderly 1999. 1999, Available at http://www.cbo.gov/doc.cfm?index=1123&type=0 Accessed on December 19, 2006
   Google Scholar
• CDC. Prevalence of disabilities and associated health conditons among adults—United States, 1999. Center for Disease Control and Prevention, Atlanta, GA 2001
   Google Scholar
• Chan D. C., Kasper J. D., Black B. S., Rabins P. V. Presence of behavioral and psychological symptoms predicts nursing home placement in community-dwelling elders with cognitive impairment in univariate but not multivariate analysis. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003; 58(6)548–554
   Google Scholar
• Cummings J. L. The Neuropsychiatry of Alzheimer's Disease and Related Dementias. Martin Dunitz, London 2003
   Google Scholar
• Farlow M., Anand R., Messina J., Jr., Hartman R., Veach J. A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. European Neurology 2000; 44(4)236–241
   PubMed Web of Science ®Google Scholar
• Freedman M., Leach L., Kaplan E., Winocur G., Shulman K. I., Delis D. Clock Drawing: A Neuropsychological Analysis. Oxford University Press, New York 1994
   Google Scholar
• Galasko D., Kershaw P. R., Schneider L., Zhu Y., Tariot P. N. Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease. Journal of American Geriatrics Society 2004; 52(7)1070–1076
   Google Scholar
• Galasko D., Schmitt F., Thomas R., Jin S., Bennett D., Ferris S. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. Journal of the International Neuropsychological Society. 2005; 11: 446–453
   PubMed Web of Science ®Google Scholar
• Gauthier L., Gauthier S. Assessment of functional changes in Alzheimer's disease. Neuroepidemiology 1990; 9(4)183–188
   Google Scholar
• Giovannetti T., Lamar M., Cloud B. S., Swenson R., Fein D., Kaplan E., et al. Different underlying mechanisms for deficits in concept formation in dementia. Archives of Clinical Neuropsychology 2001; 16(6)547–560
   Google Scholar
• Glosser G., Gallo J., Duda N., de Vries J. J., Clark C. M., Grossman M. Visual perceptual functions predict instrumental activities of daily living in patients with dementia. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 2002; 15(3)198–206
   PubMedGoogle Scholar
• Gray D. B., Hendershot G. E. The ICIDH-2: Developments for a new era of outcomes research. Archives of Physical Medicine and Rehabilitation 2000; 81(12)S10–S14, Suppl 2
   PubMed Web of Science ®Google Scholar
• Green C. R., Mohs R. C., Schmeidler J., Aryan M., Davis K. L. Functional decline in Alzheimer's disease: A longitudinal study. Journal of American Geriatrics Society 1993; 41(6)654–661
   PubMed Web of Science ®Google Scholar
• Guccione A. A., Felson D. T., Anderson J. J., Anthony J. M., Zhang Y., Wilson P. W., et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham study. American Journal of Public Health 1994; 84(3)351–358
   PubMed Web of Science ®Google Scholar
• Hebert L. E., Beckett L. A., Scherr P. A., Evans D. A. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Disease and Associated Disorders 2001; 15(4)169–173
   PubMed Web of Science ®Google Scholar
• Heron M. P., Smith B. L. Deaths: Leading causes for 2003. Natl Vital Stat Rep 2007; 55: 1–93
   PubMedGoogle Scholar
• Jefferson A. L., Barakat L. P., Giovanetti T., Paul R. H., Glosser G. Object perception impairments predict instrumental activities of daily living dependence in Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 2006; 28: 884–897
   PubMed Web of Science ®Google Scholar
• Jette A. M. Physical disablement concepts for physical therapy research and practice. Physical Therapy 1994; 74(5)380–386
   PubMed Web of Science ®Google Scholar
• Jette A. M., Assmann S. F., Rooks D., Harris B. A., Crawford S. Interrelationships among disablement concepts. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 1998; 53(5)M395–M404
   Google Scholar
• Lawton M. P. Scales to measure competence in everyday activities. Psychopharmacology Bulletin 1988; 24(4)609–614
   PubMedGoogle Scholar
• Loewenstein D. A., Acevedo A., Agron J., Issacson R., Strauman S., Crocco E., et al. Cognitive profiles in Alzheimer's disease and in mild cognitive impairment of different etiologies. Dementia and Geriatric Cognitive Disorders 2006; 21(5–6)309–315
   Google Scholar
• Mackenzie C. S., Smith M. C., Hasher L., Leach L., Behl P. Cognitive functioning under stress: Evidence from informal caregivers of palliative patients. Journal of Palliative Medicine 2007; 10(3)749–758
   PubMed Web of Science ®Google Scholar
• Marge M. Health promotion for people with disabilities: Moving beyond rehabilitation. American Journal of Health Promotion 1988; 2(4)29–44
   PubMedGoogle Scholar
• Mehta K. M., Yaffe K., Covinsky K. E. Cognitive impairment, depressive symptoms, and functional decline in older people. Journal of American Geriatric Society 2002; 50(6)1045–1050
   PubMed Web of Science ®Google Scholar
• Mendez M. F., Mendez M. A., Martin R., Smyth K. A., Whitehouse P. J. Complex visual disturbances in Alzheimer's disease. Neurology 1990; 40(3)439–443, pt 1
   Google Scholar
• Mitchell D. B., Schmitt F. A. Short- and long-term implicit memory in aging and Alzheimer's disease. Neuropsychology, Development, and Cognition. Section B: Aging. Neuropsychology and Cognition 2006; 13(3–4)611–635
   PubMed Web of Science ®Google Scholar
• Mohs R. C., Doody R. S., Morris J. C., Ieni J. R., Rogers S. L., Perdomo C. A., et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 2001; 57(3)481–488
   PubMed Web of Science ®Google Scholar
• Nagi S. Z. Some conceptual issues in disability and rehabilitation. Sociology and rehabilitation, M. B. Sussman. American Sociological Association in Cooperation with the Vocational Rehabilitation Administration, U. S. Department of Health, Education, and Welfare, Washington, DC 1965; 100–113
   Google Scholar
• NCMRR. Conceptual model of the rehabilitation process. Research Plan for the National Center For Medical Rehabilitation Research. U. S. Department of Health and Human Services, Bathesda, MD 1993; 20–28
   Google Scholar
• Pope A. M., Tarlov A. A Model for Disability and Disability Prevention. Disability in America: Toward a National Agenda for Prevention. National Academy Press, Washington, DC 1991; 76–108
   Google Scholar
• Reisberg B., Doody R., Stoffler A., Schmitt F., Ferris S., Mobius H. J. Memantine in moderate-to-severe Alzheimer's disease. New England Journal of Medicine 2003; 348(14)1333–1341
   PubMed Web of Science ®Google Scholar
• Reisberg B., Ferris S. H., Shulman E., Steinberg G., Buttinger C., Sinaiko E., et al. Longitudinal course of normal aging and progressive dementia of the Alzheimer's type: A prospective study of 106 subjects over a 3.6-year mean interval. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1986; 10(3–5)571–578
   Google Scholar
• Richardson E. D., Nadler J. D., Malloy P. F. Neuropsychologica prediction of performance measures of daily living skills in geriatric patients. Neuropsychology 1995; 9(4)565–572
   Web of Science ®Google Scholar
• Ryan C. M. Diabetes-associated cognitive dysfunction. Neuropsychology of Cardiovascular Disease, S. R. Waldstein, M. F. Elias. Lawrence Erlbaum Associates, Mahwah, NJ 2001; 61–82
   Google Scholar
• Scarmeas N., Albert S. M., Manly J. J., Stern Y. Education and rates of cognitive decline in incident Alzheimer's disease. Journal of Neurology, Neurosurgery & Psychiatry 2006; 77(3)308–316
   PubMed Web of Science ®Google Scholar
• Scarmeas N., Brandt J., Albert M., Hadjigeorgiou G., Papadimitriou A., Dubois B., et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology 2005; 62(10)1601–1608
   PubMedGoogle Scholar
• Schmitt F. A., Wichems C. H. A systematic review of assessment and treatment of moderate to severe Alzheimer's disease. Primary Care Companion Journal of Clinical Psychiatry 2006; 8(3)158–159
   PubMedGoogle Scholar
• Stern R. G., Mohs R. C., Davidson M., Schmeidler J., Silverman J., Kramer-Ginsberg E., et al. A longitudinal study of Alzheimer's disease: Measurement, rate, and predictors of cognitive deterioration. American Journal of Psychiatry 1994; 151(3)390–396
   Google Scholar
• Tariot P. N., Farlow M. R., Grossberg G. T., Graham S. M., McDonald S., Gergel I. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: A randomized controlled trial. Journal of American Medical Association 2004; 291(3)317–324
   PubMed Web of Science ®Google Scholar
• Taylor D. H., Jr., Schenkman M., Zhou J., Sloan F. A. The relative effect of Alzheimer's disease and related dementias, disability, and comorbidities on cost of care for elderly persons. Journal of Gerontology Series B: Psychological Sciences & Social Sciences 2001; 56(5)S285–S293
   Google Scholar
• Tekin S., Fairbanks L. A., O'Connor S., Rosenberg S., Cummings J. L. Activities of daily living in Alzheimer's disease: Neuropsychiatric, cognitive, and medical illness influences. American Journal of Geriatric Psychiatry 2001; 9(1)81–86
   PubMed Web of Science ®Google Scholar
• Tractenberg R. E., Weiner M. F., Cummings J. L., Patterson M. B., Thal L. J. Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: A factor analytic approach. Journal of Neuropsychiatry and Clinical Neurosciences 2005; 17(1)51–60
   Google Scholar
• Trupin L., Rice D. P., Max W. Medical expenditures for people with disabilities in the United States, 1987. US Department of Education, National Institute on Disability and Rehabilitation Research, Washington, DC 1995
   Google Scholar
• Verbrugge L. M., Jette A. M. The disablement process. Social Science & Medicine 1994; 38(1)1–14
   PubMed Web of Science ®Google Scholar
• Waldstein S. R., Katzel L. I. Hypertension and cognitive function. Neuropsychology of Cardiovascular Disease, S. R. Waldstein, M. F. Elias. Lawrence Erlbaum Associates, Mahwah, NJ 2001; 15–36
   Google Scholar
• Whiteneck G. Conceptual models of disability: Past, present, and future. Workshop on disability in America: A new look, M. J. Field, A. M. Jette, L. Martin. National Academic Press, Washington, DC 2006; 50–66
   Google Scholar
• WHO. International classification of impairments, disabilities, and handicaps: A manual of classification relating to the consequence of disease. World Health Organization, GenevaSwitzerland 1980
   Google Scholar
• WHO. International classification of functioning, disability, and health. World Health Organization, GenevaSwitzerland 2001a
   Google Scholar
• WHO. WHO publishes new guidelines to measure health. 2001b, Available at http://www.who.int Accessed on January 4, 2006
   Google Scholar
• Zarit S. H., Bottiggi K. A., Gaugler J. E. Stress and caregivers. The Encyclopedia of Stress, 2nd ed, G. Fink. Elsevier Press, Burlington, MA 2006; 197–204
   Google Scholar